Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). (Q37403983)

20 August 2017

1 reference

title

Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). (English)

1 reference

gastric inhibitory peptide receptor activity

20 August 2017

0 references

0 references

1 reference

Gene Ontology release 2020-05-02

Gene Ontology ID

GO:0016519

gastric inhibitory peptide signaling pathway

1 reference

Gene Ontology release 2020-05-02

Scott Widenmaier

2

0 references

author name string

Christopher H S McIntosh

series ordinal

1

1 reference

PubMed ID

19251046

20 August 2017

Su-Jin Kim

series ordinal

3

1 reference

20 August 2017

1 January 2009

1 reference

20 August 2017

Vitamins and Hormones

1 reference

20 August 2017

80

1 reference

20 August 2017

409-471

1 reference

Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Conflicting gastric inhibitory polypeptide data: possible causes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The mechanism whereby growth hormone-release inhibiting hormone (somatostatin) inhibits food stimulated gastric acid secretion in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Is GIP a glucagon cell constituent?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Functional GIP receptors in a hamster pancreatic beta cell line, In 111: Specific binding and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Interaction of gastric inhibitory polypeptide (GIP) with the insulin-secreting pancreatic beta cell line, In lll: characteristics of GIP binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells. Direct cross-linking, solubilization and characterization as a glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

High-density genetic map of the BRCA1 region of chromosome 17q12-q21

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Somatostatin: Abundance of Immunoreactive Hormone in Rat Stomach and Pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Molecular defects in insulin secretion in type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Therapeutic approaches to preserve islet mass in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Biology of incretins: GLP-1 and GIP

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The Sp transcription factor family is involved in the cellular expression of the human GIP-R gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide: a gut hormone with anabolic functions

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Direct metabolic effects of gastric inhibitory polypeptide (GIP): dissociation at physiological levels of effects on insulin-stimulated fatty acid and glucose incorporation in rat adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Incretin hormone expression in the gut of diabetic mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gut hormones in tropical malabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene in a mouse neuroendocrine tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Structure of the rat glucose-dependent insulinotropic polypeptide receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A Gastric Inhibitory Polypeptide. I. The Amino Acid Composition and the Tryptic Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A Gastric Inhibitory Polypeptide II: The Complete Amino Acid Sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastrointestinal Hormones and the Control of Insulin Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Further purification of a polypeptide demonstrating enterogastrone activity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

1 reference

7 January 2021

Selective neurohormonal interactions in islet cell secretion in the isolated perfused human pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) im man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A comparison of the ability of serum and monoclonal antibodies to gastric inhibitory polypeptide to detect immunoreactive cells in the gastroenteropancreatic system of mammals and reptiles

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The endocrine pancreas of Alligator mississippiensis. An immunocytochemical investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Identification of the intestinal cell storing gastric inhibitory peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A novel form of gastric inhibitory polypeptide (GIP) isolated from bovine intestine using a radioreceptor assay. Fragmentation with staphylococcal protease results in GIP1-3 and GIP4-42, fragmentation with enterokinase in GIP1-16 and GIP17-42

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of motilin and octapeptide of cholecystokinin on antral and duodenal myoelectric activity in the interdigestive state and during inhibition by secretin and gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric Inhibitory Polypeptide (GIP) and Insulin Release in Duodenal Ulcer Patients*

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) stimulates cortisol secretion, cAMP production and DNA synthesis in an adrenal adenoma responsible for food-dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Bi-directional signaling between gastrointestinal peptide hormone receptors and epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Absence of hepatic extraction of gastric inhibitory polypeptide in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Basolateral D-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulin release from genetically engineered K cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Secretin, 100 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Xenin reduces feed intake by activating the ventromedial hypothalamus and influences gastrointestinal transit rate in chicks.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Potential role of pancreatic and enteric hormones in regulating bone turnover.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The GIP receptor on pancreatic beta cell tumor: molecular identification by covalent cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The incretin concept today

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The [pre-] history of the incretin concept

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

New developments in the incretin concept

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Circulation and degradation of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

What do we know about the secretion and degradation of incretin hormones?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP-(3–42) does not antagonize insulinotropic effects of GIP at physiological concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Modification of salivary duct electrolyte transport in rat and rabbit by physalaemin, VIP, GIP and other enterohormones

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide: differential effects on hepatic artery vs. portal vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Mechanisms of action of glucagon-like peptide 1 in the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The biology of incretin hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The role of gut hormones in glucose homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Endocrine pancreatic control of the release of gastric inhibitory polypeptide. A possible physiological role for C-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulation of release of insulin by an extract of intestinal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Influence of gastric inhibitory polypeptide antiserum on glucose-induced insulin secretion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of Exogenous or Endogenous Gastric Inhibitory Polypeptide (GIP) on Plasma Triglyceride Responses in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMP-dependent protein kinase/Rap1-mediated pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The role for endoplasmic reticulum stress in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Functional receptors for VIP, GIP, glucagon-29 and -37 in the HGT-1 human gastric cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric Inhibitory Polypeptide (GIP) Stimulated by Fat Ingestion in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Homologous Desensitization of the Insulinotropic Glucagon-Like Peptide-I(7–37) Receptor on Insulinoma (HIT-T15) Cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

1 reference

7 January 2021

Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The Effect of Adrenoceptor Blockade on the Release of Gastric Inhibitory Polypeptide after Intraduodenal Glucose in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A novel lipid-anchored A-kinase Anchoring Protein facilitates cAMP-responsive membrane events

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The repertoire of G-protein-coupled receptors in fully sequenced genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Improved biological activity of Gly2- and Ser2-substituted analogues of glucose-dependent insulinotrophic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological increti

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Characterisation and glucoregulatory actions of a novel acylated form of the (Pro3)GIP receptor antagonist in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems present in rat gastric glands

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Neural modulation of glucose-dependent insulinotropic peptide (GIP) and insulin secretion in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The hepatic extraction of gastric inhibitory polypeptide and insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Family-B G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of gastrointestinal hormones in postprandial reduction of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Isolation and characterization of the gene encoding rat glucose-dependent insulinotropic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Developmental expression of the glucose-dependent insulinotropic polypeptide gene in rat intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Molecular cloning of rat glucose-dependent insulinotropic peptide (GIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

[Ser2]- and [SerP2] incretin analogs: comparison of dipeptidyl peptidase IV resistance and biological activities in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

On the physiology of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The pathogenesis of NIDDM involves a defective expression of the GIP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Cell physiology of cAMP sensor Epac

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric Inhibitory Polypeptide: Structure and Chromosomal Localization of the Human Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications for postprandial lipemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Cell-specific expression of the glucose-dependent insulinotropic polypeptide gene functions through a GATA and an ISL-1 motif in a mouse neuroendocrine tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP and insulin responses to a test meal in healthy and obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Fasting and postprandial plasma GIP values in man measured with seven different antisera.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Lack of effect of exogenous or endogenous gastric inhibitory polypeptide on the elimination rate of Intralipid in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP or not GIP? That is the question

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A novel mechanism for the suppression of a voltage-gated potassium channel by glucose-dependent insulinotropic polypeptide: protein kinase A-dependent endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and dow

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP and GLP-1(7-36)amide secretion in response to intraduodenal infusions of nutrients in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gut hormones in stimulation of gastroduodenal alkaline secretion in conscious dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Adrenergic modulation of gastric somatostatin release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Immunoreactive gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Pax 4 and 6 regulate gastrointestinal endocrine cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Depression of insulin release by anti-GIP serum after oral glucose in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Apoptosis in the pathophysiology of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Acid-induced gastric inhibitory polypeptide secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Localization of glucose-dependent insulinotropic polypeptide (GIP) to a gene cluster on chromosome 17q

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of phosphatidylinositol 3-kinasegamma in the beta-cell: interactions with glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The discovery of glucagon-like peptide 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K(+) currents in beta-cells: a possible glucose-dependent insulinotropic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Inhibition of Kv2.1 voltage-dependent K+ channels in pancreatic beta-cells enhances glucose-dependent insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Structural requirements for gastric inhibitory polypeptide (GIP) receptor binding and stimulation of insulin release

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Structure-function analysis of a series of novel GIP analogues containing different helical length linkers

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

International Union of Pharmacology. XXXV. The glucagon receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastrointestinal somatostatin: distribution, secretion and physiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dipeptidyl peptidase IV inhibitors and diabetes therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastrointestinal somatostatin in man and dog

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide stimulated secretion of somatostatinlike immunoreactivity from the stomach: inhibition by acetylcholine or vagal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Autonomic nervous control of gastric somatostatin secretion from the perfused rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Enkephalinergic control of somatostatin secretion from the perfused rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP receptors and signal-transduction mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide: the neglected incretin revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Functional development of the human gastrointestinal tract: hormone- and growth factor-mediated regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide and insulin-like immunoreactivity in saliva following sham-fed and swallowed meals

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The isolation and sequencing of human gastric inhibitory peptide (GIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The metabolic role of GIP: physiology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The effect of dietary modification and hyperglycaemia on gastric emptying and gastric inhibitory polypeptide (GIP) secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Interaction of acetylcholine and gastric inhibitory polypeptide on endocrine and exocrine rat pancreatic secretion: augmentation of acetylcholine-induced amylase and volume secretion by the insulinotropic action of gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP potentiates CCK stimulated pancreatic enzyme secretion: correlation of anatomical structures with the effects of GIP and CCK on amylase secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Lack of a direct effect of the autonomic nervous system on glucose-stimulated gastric inhibitory polypeptide (GIP) secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus- pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Renal effects on serum gastric inhibitory polypeptide (GIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Mannitol and glucose: effects on gastric acid secretion and endogenous gastric inhibitory polypeptide (GIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Improved stability, insulin-releasing activity and antidiabetic potential of two novel N-terminal analogues of gastric inhibitory polypeptide: N-acetyl-GIP and pGlu-GIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of endogenous gastric inhibitory polypeptide (GIP) on the removal of triacylglycerol in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Response of gastric inhibitory polypeptide to fat ingestion in normal dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of vagus nerve in secretion of gastric inhibitory polypeptide in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Absence of a relationship between immunoreactive-gastrin and somatostatin-like immunoreactivity secretion in the perfused rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

From plants to man: the GPCR "tree of life".

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The New Biology of Gastrointestinal Hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Clinical endocrinology and metabolism. Cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Type 2 diabetes-a matter of beta-cell life and death?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduced gastric acid inhibitory effect of a pGIP(1-30)NH2 fragment with potent pancreatic amylase inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Heterologous desensitization of insulin secretion by GIP (glucose-dependent insulinotropic peptide) in INS-1 cells: the significance of Galphai2 and investigations on the mechanism involved

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Potentiation of glucose-induced insulin secretion in the perfused rat pancreas by porcine GIP (gastric inhibitory polypeptide), bovine GIP, and bovine GIP(1-39)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Insulin release from isolated rat pancreatic islets induced by α-ketoisocaproic acid, L-leucine, D-glucose or D-glyceraldehyde: Effect of gastric inhibitory polypeptide or glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Isolation of a murine glucose-dependent insulinotropic polypeptide (GIP) cDNA from a tumor cell line (STC6-14) and quantification of glucose-induced increases in GIP mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric emptying and release of incretin hormones after glucose ingestion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Commercially available preparations of porcine glucose-dependent insulinotropic polypeptide (GIP) contain a biologically inactive GIP-fragment and cholecystokinin-33/-39

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide release into the portal vein in response to intraduodenal amino acid loads in anesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Release of bombesin-like immunoreactivity from the isolated perfused rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Lack of effect of gastric inhibitory polypeptide on hepatic and extrahepatic insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Characterization of rat gastric inhibitory peptide cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Stimulatory effect of xenin-8 on insulin and glucagon secretion in the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) release by actively transported, structurally similar carbohydrates

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Immunocytochemical localization of a gastric inhibitory polypeptide-like material within A-cells of the endocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Two 3',5'-cyclic-adenosine monophosphate response elements in the promoter region of the human gastric inhibitory polypeptide gene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The evaluation of gastric inhibitory polypeptide (GIP) as the enterogastrone

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide stimulates insulin secretion via increased cyclic AMP and [Ca2+]1 and a wortmannin-sensitive signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide and splanchnic blood perfusion: augmentation of the islet blood flow increase in hyperglycemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide. Response to oral glucose after vagotomy and pyloroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A point mutation in the glucose-dependent insulinotropic peptide receptor confers constitutive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of Regulator of G Protein Signaling in Desensitization of the Glucose-Dependent Insulinotropic Peptide Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The cysteine of the cytoplasmic tail of glucose-dependent insulinotropic peptide receptor mediates its chronic desensitization and down-regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide (GIP) gene expression in the rat salivary gland

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The effect of the intestinal polypeptides, IRP and GIP, on insulin release and glucose tolerance in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

1 reference

7 January 2021

Gastric inhibitory polypeptide receptor, a member of the secretin- vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Ultrastructural localization of gastric inhibitory polypeptide (GIP) in a well characterized endocrine cell of canine duodenal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

A stereological evaluation of secretin and gastric inhibitory peptide-containing mucosal cells of the perinatal small intestine of the pig

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

The rate of intestinal glucose absorption is correlated with plasma glucose-dependent insulinotropic polypeptide concentrations in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Are ionic fluxes of pancreatic beta cells a target for gastric inhibitory polypeptide?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation of food restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Regulation of glucose-dependent insulinotropic polypeptide release by protein in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic polypeptide gene expression in the stomach: revealed by a transgenic mouse study, in situ hybridization and immunohistochemical staining

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GIP biology and fat metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Functional GIP receptors are present on adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Secretion of gastric inhibitory polypeptide in patients with bile duct obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of glucose-dependent insulinotropic peptide on osteoclast function

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

Effects of synthetic human gastric inhibitory polypeptide on splanchnic circulation in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2808%2900615-8

7 January 2021

10.1016/S0083-6729(08)00615-8

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19251046